nobel
lectur
paul
ehrlich
liken
antibodyantigen
interact
lock
key
reason
antitoxin
antibodi
contain
solut
serum
immun
anim
must
ident
cellular
receptor
realli
wellmad
key
open
differ
lock
time
took
almost
five
decad
immunofluoresc
microscopi
use
confirm
cellular
origin
antibodi
major
stride
b
cell
antibodi
field
follow
develop
hybridoma
technolog
produc
monoclon
antibodi
discoveri
somat
rearrang
b
cell
differenti
respons
antibodi
diversif
subsequ
explos
avail
monoclon
antibodi
led
revolutionari
diagnost
therapeut
research
reagent
distinguish
differ
type
immun
cell
togeth
discoveri
allow
us
probe
humor
immun
level
antigenspecif
b
cell
method
probe
antigenspecif
b
cell
respons
advanc
understand
har
remark
breadth
b
cell
repertoir
exquisit
specif
individu
b
cell
develop
vaccin
candid
elicit
protect
antibodi
antibodi
prevent
diseas
given
prophylact
antibodi
given
therapi
onset
diseas
mani
vaccin
current
avail
origin
develop
empir
either
inactiv
attenu
administ
subunit
pathogen
howev
vaccin
develop
pathogen
tradit
difficult
vaccin
may
reli
deeper
investig
b
cell
respons
antigen
expos
surfac
pathogen
discoveri
broadli
neutral
antibodi
bnab
protect
infect
across
divers
viral
isol
intensifi
effort
understand
development
pathway
rare
b
cell
produc
antibodi
insight
ontogeni
rare
b
cell
could
allow
design
stepwis
vaccin
regimen
stimul
germlin
precursor
expand
matur
produc
circul
bnab
could
protect
hiv
acquisit
rsv
stabil
version
fusion
f
protein
prefus
conform
led
insight
b
cell
respons
infect
gener
potenti
safer
efficaci
vaccin
candid
influenza
also
perform
fusion
stem
region
hemagglutinin
protein
identif
b
cell
target
rel
conserv
site
spur
research
develop
univers
influenza
vaccin
like
rsv
hiv
influenza
fusion
protein
ebv
cmv
exist
prefus
conform
stabil
prefus
state
could
greatli
acceler
vaccin
develop
pathogen
rare
memori
b
cell
produc
antibodi
specif
ebv
fusion
machineri
isol
neutral
b
cell
epitheli
cell
infect
new
paradigm
malaria
vaccin
develop
also
emerg
discoveri
igm
igd
memori
b
cell
target
merozoit
surfac
protein
rapidli
respond
malaria
reinfect
highli
potent
neutral
antibodi
target
novel
conserv
site
circumsporozoit
protein
isol
b
cell
togeth
exampl
demonstr
import
studi
antigenspecif
humor
respons
infecti
diseas
solut
crystal
structur
surfac
protein
varieti
pathogen
conform
stabil
antigen
applic
method
summar
review
probe
antigenspecif
b
cell
respons
creat
new
opportun
systemat
ration
vaccin
design
hiv
rsv
ebv
malaria
mani
pathogen
studi
b
cell
respons
inform
vaccin
design
also
advanc
understand
antibodymedi
autoimmun
diseas
rheumatoid
arthriti
system
lupu
erythematosu
matur
b
cell
receptor
capac
bind
selfantigen
although
cell
potenti
pathogen
delet
b
cell
high
affin
selfantigen
apoptosi
anergi
b
cell
low
affin
selfantigen
absenc
cell
help
combin
togeth
protect
autoimmun
diseas
mice
studi
autoantigenspecif
b
cell
detail
analysi
b
cell
subset
pathogen
potenti
human
could
lead
better
understand
prevent
treat
autoimmun
diseas
although
term
antigenspecif
b
cell
use
throughout
minireview
denot
analysi
b
cell
base
bind
b
cell
receptor
bcr
specif
antigen
use
bait
import
keep
mind
bcr
within
polyclon
b
cell
repertoir
exhibit
spectrum
polyreact
one
end
spectrum
highli
polyreact
bcr
abl
bind
multipl
structur
unrel
antigen
physiolog
relev
affin
frequenc
polyreact
normal
adult
human
b
cell
repertoir
estim
b
cell
igg
memori
b
cell
intestin
iga
igg
plasmablast
end
spectrum
mono
reactiv
bcr
activ
encount
singl
cognat
antigen
although
except
accumul
somat
hypermut
within
variabl
region
bcr
process
affin
matur
gener
thought
lead
increas
affin
specif
cognat
antigen
sever
gener
techniqu
commonli
use
identifi
antigenspecif
b
cell
tabl
b
cell
enzym
link
immunospot
elispot
techniqu
reli
principl
captur
secret
antibodi
vicin
cell
b
cell
elispot
antibodi
secret
b
cell
asc
present
sampl
differenti
vitro
ad
plate
coat
antigen
interest
antigenspecif
antibodi
bind
close
proxim
locat
individu
b
cell
produc
antibodi
enzym
fluoresc
label
secondari
antibodi
use
visual
spot
antibodi
secret
bind
platebound
antigen
locat
asc
spot
correspond
antibodi
produc
singl
antigenspecif
b
cell
therefor
techniqu
extrem
sensit
secondari
antibodi
conjug
combinatori
color
bead
also
use
detect
antibodi
secret
individu
b
cell
advantag
multiplex
assay
one
limit
assay
requir
antibodi
secret
b
cell
therebi
limit
assay
subset
b
cell
repertoir
name
asc
memori
b
cell
stimul
vitro
differenti
asc
prior
addit
antigenco
plate
antigenspecif
b
cell
identifi
elispot
gener
avail
downstream
analysi
limit
dilut
anoth
techniqu
use
isol
antigenspecif
b
cell
approach
primari
cell
dilut
serial
individu
b
cell
separ
microwel
plate
b
cell
cultur
expand
ex
vivo
andor
immort
use
ebv
well
contain
monoclon
antibodi
antigenspecif
b
cell
select
screen
cultur
supernat
monoclon
antibodi
bind
antigen
interest
although
antibodi
sequenc
clone
requir
ex
vivo
cultur
prior
select
preclud
determin
transcript
profil
origin
b
cell
approach
techniqu
potenti
timeconsum
labori
use
microfluid
robot
greatli
improv
throughput
select
antigenspecif
b
cell
advanc
singl
cell
next
gener
sequenc
technolog
allow
high
throughput
transcript
profil
sequenc
pair
immunoglobulin
heavi
light
chain
approach
antigen
specif
test
monoclon
antibodi
clone
produc
use
sequenc
data
method
use
identifi
antigenspecif
b
cell
undergon
clonal
expans
vaccin
acut
infect
flow
cytometri
common
method
use
singl
cell
analysi
isol
flow
cytometrybas
analysi
antigenspecif
b
cell
depend
label
antigen
fluoresc
tag
allow
detect
fluorochrom
either
attach
coval
via
chemic
conjug
antigen
express
recombin
fusion
protein
attach
noncoval
biotinyl
antigen
biotinyl
fluorochromeconjug
streptavidin
ad
gener
label
tetram
antigen
biotinyl
antigen
ratio
biotin
antigen
import
sinc
streptavidin
potenti
bind
four
biotin
ratio
biotin
antigen
clump
precipit
antigen
solut
occur
soon
streptavidin
ad
altern
site
direct
biotinyl
accomplish
ad
either
avitag
bioeas
tag
recombin
antigen
prior
express
sitespecif
biotinyl
util
research
must
keep
mind
tag
may
occlud
epitop
recognit
b
cell
problemat
vaccin
antigen
protein
oligomer
multipl
tag
may
incorpor
possibl
result
aggreg
anoth
import
consider
potenti
confound
b
cell
repertoir
bind
fluorochrom
streptavidin
linker
rather
antigen
interest
bind
fluorochrom
linker
streptavidin
bcr
human
mice
never
expos
antigen
gener
low
affin
bcr
gener
express
potenti
polyreact
b
cell
dual
label
antigen
separ
label
two
differ
fluorochrom
use
identifi
doubl
posit
b
cell
remov
confound
b
cell
bind
fluorochrom
howev
even
tetram
util
dual
label
streptavidinspecif
b
cell
contamin
doubl
posit
popul
fulli
remov
confound
fluorochrom
streptavidin
linker
decoy
tetram
use
identifi
contamin
b
cell
approach
fluorochrom
use
identifi
antigenspecif
b
cell
conjug
differ
fluorochrom
emiss
spectrum
alter
fluoresc
reson
energi
transfer
fret
decoybind
b
cell
therefor
exclud
true
antigenspecif
b
cell
notabl
critic
use
sourc
fluorochrom
conjug
streptavidin
tetram
decoy
reagent
conjug
method
recombin
streptavidin
protein
fluorochrom
like
rphycoerythrin
vari
enough
compani
compani
alter
epitop
avail
b
cell
bind
one
weak
flow
cytometr
approach
relianc
antigen
readili
conjug
fluorochrom
biotinyl
addit
recombin
protein
synthes
peptid
label
polysaccharid
lipid
hapten
viruslik
particl
pseudo
virus
also
use
identifi
antigenspecif
cell
flow
cytometri
epitopespecif
b
cell
identifi
screen
bacteriophagedisplay
microarray
peptid
librari
polyclon
antibodi
target
nativ
antigen
select
conform
epitop
fuse
fluoresc
protein
use
flow
cytometri
technolog
advanc
increas
number
simultan
measur
paramet
antigenspecif
b
cell
character
cell
surfac
marker
intracellular
stain
addit
immunoglobulin
captur
assay
flow
cytometrybas
adapt
elispot
assay
streptavidinconjug
antibodi
carri
four
biotinyl
antiigg
antibodi
use
simultan
bind
plasmablast
captur
secret
antibodi
follow
fluorescentlabel
antigen
detect
antigenspecif
plasmablast
mean
fluoresc
intens
measur
flow
cytometri
normal
level
bcr
express
also
provid
measur
rel
amount
antigen
bind
b
cell
use
rough
surrog
bind
affin
preincub
b
cell
increas
concentr
monomer
antigen
prior
label
tetramer
antigen
also
use
quantifi
bind
affin
cell
express
high
affin
bcr
bind
monomer
antigen
low
concentr
wherea
low
affin
bcr
requir
higher
concentr
monomer
antigen
compet
inhibit
tetram
bind
individu
cell
also
isol
fluoresc
activ
cell
sort
fac
downstream
analysi
includ
bcr
sequenc
clone
bcr
affin
measur
vitro
prolifer
transcript
profil
method
recent
develop
improv
sensit
detect
rare
antigenspecif
b
cell
magnet
nanoparticl
conjug
antibodi
target
fluorochrom
antigen
interest
allow
enrich
antigenspecif
b
cell
prior
flow
cytometri
approach
particularli
use
detect
rare
antigenspecif
b
cell
autoreact
b
cell
memori
b
cell
plasmablast
magnet
enrich
strategi
allow
analysi
significantli
cell
shorter
period
time
concentr
cell
interest
prior
flow
cytometri
figur
notabl
method
seek
identifi
popul
cell
low
frequenc
background
nois
inher
detect
system
magnifi
respect
signal
interest
especi
signal
weak
therefor
detect
antigenspecif
popul
interest
follow
consider
critic
use
decoy
exclud
b
cell
unwant
specif
care
design
flow
cytometri
panel
avoid
emiss
spillov
channel
antigen
interest
choos
brightest
fluorochrom
like
rphycoerythrin
allophycocyanin
vivo
method
probe
antigenspecif
b
cell
respons
presenc
antigenpres
cell
cell
helper
increas
mechanist
understand
humor
immun
respons
vaccin
infect
autoimmun
adopt
transfer
b
cell
distinguish
recipi
lymphocyt
take
advantag
mous
strain
allel
variat
mice
devoid
b
cell
adopt
transfer
b
cell
come
wildtyp
mice
mice
express
transgen
bcr
tabl
antigenspecif
b
cell
analyz
use
techniqu
describ
microscopi
anoth
gener
techniqu
use
identifi
antigenspecif
cell
vivo
offer
advantag
direct
visual
first
report
applic
techniqu
demonstr
cellular
origin
antibodi
fluoresceinconjug
antibodi
ovalbumin
human
immunoglobulin
use
stain
tissu
section
spleen
hyperimmun
rabbit
sinc
group
fluoresc
label
antigen
local
antigenspecif
b
cell
microscopi
advanc
laser
captur
dissect
microscopi
alreadi
use
cell
field
also
provid
opportun
isol
individu
antigenspecif
b
cell
downstream
analysi
includ
sequenc
clone
bcr
transcript
profil
howev
antigen
stain
bcr
situ
challeng
depend
bind
antigen
pathogen
cellular
receptor
alter
bcr
specif
tissu
fixat
process
twophoton
multiphoton
microscopi
abil
resolv
imag
greater
depth
less
photobleach
confoc
microscopi
result
technolog
allow
realtim
imag
live
intact
lymphoid
tissu
mice
permit
direct
vivo
observ
immun
cell
interact
dynam
movement
interact
antigenspecif
b
cell
studi
vivo
combin
adopt
transfer
individu
b
cell
isol
limit
dilut
fac
twophoton
microscopi
human
mous
model
power
tool
translat
experi
mice
applic
human
transgen
mice
produc
human
cytokin
knockin
replac
use
support
human
hematopoiet
stem
cell
transgen
mice
complet
human
mous
immunoglobulin
loci
provid
opportun
recapitul
breadth
human
b
cell
repertoir
serv
valuabl
tool
therapeut
antibodi
discoveri
howev
one
caveat
allel
frequenc
found
b
cell
repertoir
mous
model
may
necessarili
recapitul
found
human
mass
cytometri
potenti
provid
highdimension
analysi
antigenspecif
b
cell
method
heavi
metal
ion
tag
rather
fluorochrom
use
label
cell
sinc
data
collect
timeofflight
mass
spectrometri
uniqu
paramet
simultan
measur
singl
sampl
without
signific
spillov
channel
need
compens
mass
cytometri
heavi
metallabel
tetram
construct
use
streptavidin
mass
cytometri
metallabel
peptidemhc
tetram
use
success
identifi
character
antigenspecif
cell
knowledg
yet
appli
antigenspecif
b
cell
one
limit
approach
cell
unavail
downstream
analysi
sinc
vapor
plasma
torch
atom
ion
tag
howev
simultan
detect
mani
surfac
marker
intracellular
cytokin
transcript
factor
detect
signal
molecul
individu
cell
previous
possibl
tradit
fluoresc
label
applic
mass
cytometri
dimension
reduct
algorithm
could
help
dissect
complex
b
cell
compart
provid
higher
resolut
view
b
cell
develop
reveal
novel
subset
antigenspecif
b
cell
involv
mediat
autoimmun
diseas
protect
infect
horizon
singl
cell
rnasequenc
rnaseq
technolog
potenti
revolution
studi
antigenspecif
immun
cell
abil
gener
librari
tetram
uniqu
barcod
could
allow
simultan
examin
gene
express
profil
larg
number
cell
differ
antigen
specif
singl
experi
combin
barcod
tetram
oligonucleotideconjug
antibodi
rnaseq
simultan
measur
protein
gene
express
antigenspecif
cell
could
increas
amount
unbias
multiom
inform
individu
antigenspecif
cell
normal
diseas
state
aid
ration
design
vaccin
therapeut
ongo
analysi
antigenspecif
b
cell
respons
led
develop
new
diagnost
therapeut
research
reagent
method
studi
antigenspecif
b
cell
respons
increasingli
appli
tackl
diseas
like
hiv
rsv
autoimmun
diseas
immun
respons
either
fail
protect
clear
diseas
enhanc
diseas
respons
diseas
consider
opportun
exist
horizon
appli
method
myriad
diseas
b
cell
play
activ
role
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
